etoposide/cisplatin

DRUG2 trials

Sponsors

GlaxoSmithKline, AbbVie (prior sponsor, Abbott)

Conditions

Small Cell Lung CancerSolid Tumors

Phase 1

A Study Evaluating the Safety of ABT-263 in Combination With Etoposide/Cisplatin in Subjects With Cancer

CompletedNCT00878449

AbbVie (prior sponsor, Abbott)Solid Tumors

Start: 2009-10-31End: 2011-07-31Updated: 2018-06-06

Phase 3

Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults

CompletedNCT00043927

GlaxoSmithKlineSmall Cell Lung Cancer

Start: 2001-04-30Target: 760Updated: 2013-08-21